Gilead (GILD) Breast Cancer Drug Gets Positive CHMP Opinion Posted byZacks Equity Research October 18, 2021 Leave a comment on Gilead (GILD) Breast Cancer Drug Gets Positive CHMP Opinion Gilead’s (GILD) application for breast cancer drug gets positive opinion for approval from EMA’s CHMP.